Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessment of EGFR mutation status using cell-free DNA from bronchoalveolar lavage fluid.

Clinical chemistry and laboratory medicine - 28 Aug 2017

Park Sojung, Hur Jae Young, Lee Kye Young, Lee Jae Cheol, Rho Jin Kyung, Shin Sun Hwa, Choi Chang-Min

Abstract excerpt

BACKGROUND: Much attention has been focused on epidermal growth factor receptor (EGFR) mutation testing since the introduction of EGFR-tyrosine kinase inhibitors have improved survival in EGFR-positive lung cancer patients. Liquid biopsy using circulating tumor cells or cell-free DNA (cfDNA) has enabled less invasive testing, but requires a highly sensitive method. To date, liquid biopsy using bronchoalveolar...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Bronchoalveolar Lavage Fluid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Neoplasm Staging

Share to Peptide Nucleic Acids

Share to Polymerase Chain Reaction

Source

Identifiers

PMID: 28195541
DOI: 10.1515/cclm-2016-0302

Genes

EGFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assessment of EGFR mutation status using cell-free DNA from bronchoalveolar lavage fluid.PMID 28195541Read ↗

Analysis of EGFR mutation status in malignant pleural effusion and plasma from patients with advanced lung adenocarcinoma.Semantic proximity Read ↗

Correlation of epidermal growth factor receptor mutation status in plasma and tissue samples of patients with non-small cell lung cancer.Semantic proximity Read ↗

Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping.Semantic proximity Read ↗

Highly sensitive detection of driver mutations from cytological samples and cfDNA in lung cancer.Semantic proximity Read ↗

Profiling Cell-Free DNA from Malignant Pleural Effusion for Oncogenic Driver Mutations in Patients with Treatment-Naive Stage IV Adenocarcinoma: A Multicenter Prospective Study.Semantic proximity Read ↗

Molecular profiling and utility of cell-free DNA in nonsmall carcinoma of the lung: Study in a tertiary care hospital.Semantic proximity Read ↗

Detection of activating and acquired resistant mutation in plasma from EGFR-mutated NSCLC patients by peptide nucleic acid (PNA) clamping-assisted fluorescence melting curve analysisSemantic proximity Read ↗

Assessment of real-time PCR method for detection of EGFR mutation using both supernatant and cell pellet of malignant pleural effusion samples from non-small-cell lung cancer patients.Semantic proximity Read ↗

The detection and significance of EGFR and BRAF in cell-free DNA of peripheral blood in NSCLC.Semantic proximity Read ↗

Dynamic plasma EGFR mutation status as a predictor of EGFR-TKI efficacy in patients with EGFR-mutant lung adenocarcinoma.Semantic proximity Read ↗

Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancerSemantic proximity Read ↗

Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.